War on Carcinogens: Industry Disputes Human Relevance of Chemicals Causing Cancer in Laboratory Animals Based on Unproven Hypotheses, Using Kidney Tumors as an Example

References

• Weisburger EK. History of the bioassay program of the National Cancer Institute. Prog Exp Tumor Res. 1983;26:187-201.
   PubMed Web of Science ®Google Scholar
• Huff J. The Legacy of David Platt Rall. Scientific, environmental, public health, and regulatory contributions. Eur J Oncol. 2000;5:85-100.
   Google Scholar
• Huff J. David Rall and the national toxicology program. Environ Health Perspect. 2005;113:A152.
   PubMed Web of Science ®Google Scholar
• IARC. Tobacco Smoking, Second-hand Tobacco Smoke. Smokeless Tobacco in: Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-318.
   Google Scholar
• RoC/NTP. Tobacco-related exposures: smokeless tobacco, environmental tobacco smoke, tobacco smoking in: NTP Rep Carcinog. 2011;12:408-14.
   PubMedGoogle Scholar
• Davis D. The Secret History of the War on Cancer 2007. New York:Basic Books, NY, 505 pp.
   Google Scholar
• Epstein SS. The Politics of Cancer Revisited 1998. East Ridge Press, Fremont Center, NY, 770 pp.
   Google Scholar
• Michaels D. Doubt is Their Product: How Industry's Assault on Science Threatens Your Health 2008. Oxford University Press, NY, 372 pp.
   Google Scholar
• American Council on Science and Health. A summary of America’s War on “Carcinogens”: Reassessing the use of animal tests to predict human cancer risk. 2005. In: Whelan E M, Ross G L, Stimola A N, editors. 2005. Available at http://www.acsh.org/wp-content/uploads/2012/04/20050126_WOCSummary.pdf
   Google Scholar
• Huff J. Industry influence on occupational and environmental public health. Int J Occup Environ Health. 2007;13:107-17.
   PubMed Web of Science ®Google Scholar
• Melnick RL, Kamel F, Huff J. Declaring chemicals “not carcinogenic to humans” requires validation, not speculation. Environ Health Perspect. 2003;111:A203-4.
   PubMed Web of Science ®Google Scholar
• Hard GC. Significance of the renal effects of ethyl benzene in rodents for assessing human carcinogenic risk. Toxicol Sci. 2002;69:30-41.
   PubMed Web of Science ®Google Scholar
• Hard GC, Khan KN. A contemporary overview of chronic progressive nephropathy in the laboratory rat, and its significance for human risk assessment. Toxicol Pathol. 2004;32:171–80.
   PubMed Web of Science ®Google Scholar
• Hard GC, Seely JC, Betz LJ, Hayashi SM. Re-evaluation of the kidney tumors and renal histopathology occurring in a 2-year rat carcinogenicity bioassay of quercetin. Food Chem Toxicol. 2007;45:600-8.
   PubMed Web of Science ®Google Scholar
• Hard GC, Johnson KJ, Cohen SM. A comparison of rat chronic progressive nephropathy with human renal disease—Implications for human risk assessment. Crit. Rev. Toxicol. 2009;39:332–46.
   PubMed Web of Science ®Google Scholar
• Hard GC, Bruner RH, Cohen SM, Pletcher JM, Regan KS. Renal histopathology in toxicity and carcinogenicity studies with tert-butyl alcohol administered in drinking water to F344 rats: a pathology working group review and re-evaluation. Regul Toxicol Pharmacol. 2011;59:430-6.
   PubMed Web of Science ®Google Scholar
• Travlos GS, Hard GC, Betz LJ, Kissling GE. Chronic progressive nephropathy in male F344 rats in 90-day toxicity studies: its occurrence and association with renal tubule tumors in subsequent 2-year bioassays. Toxicol Pathol. 2011;39:381-9.
   PubMed Web of Science ®Google Scholar
• Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012 Jan 4. doi: 10.3322/caac.20141. [Epub ahead of print]
   Google Scholar
• Buzio L, Tondel M, De Palma G, Buzio io L, Tondel M, De Palma G, Buzio C, Franchini I, Mutti A, et al.. Occupational risk factors for renal cell cancer. An Italian case-control study. Med Lav. 2002;93:303-9.
   PubMedGoogle Scholar
• Huff J, Melnick R, Tomatis L, LaDou J, Teitelbaum D. Trichloroethylene and cancers in humans. Toxicology. 2004;197:185-7.
   PubMed Web of Science ®Google Scholar
• Kluwe WM, Abdo KM, Huff J. Chronic kidney disease and organic chemical exposures: evaluations of causal relationships in humans and experimental animals. Fundam Appl Toxicol. 1984;4:889-901.
   PubMedGoogle Scholar
• Pesch B, Haerting J, Ranft U, Klimpel A, Oelschlägel B, Schill W. Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study. Int J Epidemiol. 2000;29:1014-24.
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency (U.S. EPA). Toxicological review of trichloroethylene (CAS No. 79-01-6) 2011. EPA/635/R-09/011F. Available at http://www.epa.gov/iris/supdocs/0199index.html
   Google Scholar
• IARC. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Accessed July 2013. http://monographs.iarc.fr/ENG/Monographs/PDFs/index.php
   Google Scholar
• RoC/NTP. Report on Carcinogens. http://ntp.niehs.nih.gov/ntp/roc/twelfth/roc12.pdf Accessed July 2013
   Google Scholar
• Bruner RH, Greaves P, Hard GC, Regan KS, Ward JM, David RM. Histopathologic changes in the kidneys of male F344 rats from a 2-year inhalation carcinogenicity study of tetrahydrofuran: a pathology working group review and re-evaluation. Regul Toxicol Pharmacol. 2010;58:100-5.
   PubMed Web of Science ®Google Scholar
• Hard GC, Seely JC. Recommendations for the interpretation of renal tubule proliferative lesions occurring in rat kidneys with advanced chronic progressive nephropathy (CPN). Toxicol Pathol. 2005;33:641-9.
   PubMed Web of Science ®Google Scholar
• Hard GC, Whysner J, English JC, Zang E, Williams GM. Relationship of hydroquinone-associated rat renal tumors with spontaneous chronic progressive nephropathy. Toxicol Pathol. 1997;25:132-43.
   PubMed Web of Science ®Google Scholar
• Dominick MA, Robertson DG, Bleavins MR, Sigler RE, Bobrowski WF, Gough AW. Alpha 2u-globulin nephropathy without nephrocarcinogenesis in male Wistar rats administered 1-(aminomethyl)cyclohexaneacetic acid. Toxicol Appl Pharmacol. 1991;111:375-87.
   PubMed Web of Science ®Google Scholar
• Malley LA, Kennedy GL, Elliott GS, Slone TW, Mellert W, Deckardt K, et al.. Chronic toxicity and oncogenicity of N-methylpyrrolidone (NMP) in rats and mice by dietary administration. Drug Chem Toxicol. 2001;24:315-38.
   PubMed Web of Science ®Google Scholar
• Malley LA, Slone TW, Makovec GT, Elliott GS, Kennedy GL. Chronic toxicity/oncogenicity of dimethylacetamide in rats and mice following inhalation exposure. Fundam Appl Toxicol. 1995;28:80-93.
   PubMedGoogle Scholar
• Melnick RL, Burns KM, Ward JM, Huff J. Chemically exacerbated chronic progressive nephropathy not associated with renal tubular tumor induction in rats: an evaluation based on 60 carcinogenicity studies by the national toxicology program. Toxicol Sci. 2012;128:346-56.
   PubMed Web of Science ®Google Scholar
• Hard GC, Banton MI, Bretzlaff RS, Dekant W, Fowles JR, Mallett AK, et al.. Consideration of rat chronic progressive nephropathy in regulatory evaluations for carcinogenicity. Toxicol Sci. 2013;132:268-75. Advance Access published October 26, 2012. Doi:10.1093/toxsci/kfs305
   PubMed Web of Science ®Google Scholar
• United States Environmental Protection Agency (U.S. EPA). Guidelines for carcinogen risk assessment. 2005. EPA/630/P-03/001F. Available at http://www.epa.gov/cancerguidelines/.
   Google Scholar
• Hill AP. The environment and disease: Association or causation? Proc R Soc Med 1965;58:295-300.
   PubMed Web of Science ®Google Scholar
• Tomatis L. The IARC monographs program: changing attitudes towards public health. Int J Occup Environ Health. 2002;8:144-52.
   PubMed Web of Science ®Google Scholar
• Axelson O, Castleman B, Epstein S, Franco G, Giannasi F, Grandjean P, et al.. Re: Implementation of WHO Guidelines on Disclosure of Interest by members of WHO Expert Panels. Int J Occup Environ Health. 2002;8:271-3.
   PubMed Web of Science ®Google Scholar
• Axelson O, Balbus JM, Cohen G, Davis D, Donnay A, Doolittle R, et al.. Re: Regulatory Toxicology and Pharmacology. Int J Occup Environ Health. 2003;9:386-9.
   PubMed Web of Science ®Google Scholar
• Huff J. IARC monographs, industry influence, and upgrading, downgrading, and under-grading chemicals: a personal point of view. International Agency for Research on Cancer. Int J Occup Environ Health. 2002;8:249-70.
   PubMed Web of Science ®Google Scholar
• Jacobson MF, Sharpe VA, Angell M, Ashford NA, Blum A, Chary LK, et al.. Editorial policies on financial disclosure. Nat Neurosci. 2003;6:1001.
   PubMed Web of Science ®Google Scholar
• LaDou J, Teitelbaum DT, Egilman DS, Frank AL, Kramer SN, Huff J. American College of Occupational and Environmental Medicine (ACOEM): a professional association in service to industry. Int J Occup Environ Health. 2007;13:404-26.
   PubMed Web of Science ®Google Scholar